Singularity Biosciences is pioneering the next generation of regenerative wound care, orthopedic and spine biologics, including regenerative bone products, synthetic bone grafts, bone scaffolds, demineralized bone matrix and bone void fillers.
Singularity Biosciences is committed to developing breakthrough therapies for musculoskeletal conditions through:
Internal research and development, resulting in proprietary technologies and patents.
Strategic partnerships with academic institutions to translate promising bench research into clinical applications.
Collaboration with researchers and manufacturers to bring novel therapies to market.
We are always searching for the next big thing in regenerative medicine – whether it comes from internal research, academic partners or other companies. If you are a researcher, manufacturer or patent holder with an interest in collaboration, we’d like to hear from you. Our network of professionals have a track record of bringing life-changing therapeutics to market.
